Lake Street Initiates Coverage on AbCellera Biologics with Buy Rating and $19 Price Target
Abcellera Biologics
ABCL
#1326
AbCellera Biologics Falls as Lake Street Initiates Buy-Rated Coverage
Abcellera Biologics Price Chart (ABCL)
| 1h | 24h | 7d | 14d | 30d | 1y |
|---|---|---|---|---|---|
| 1.2% | 6.8% | 15.1% | 19.0% | 22.9% | 183.0% |
ABCL Converter
Abcellera Biologics Historical Prices
| 24h Range | $9.60 – $10.50 |
|---|---|
| 7d Range | $9.60 – $11.54 |
| 52w Range | $2.73 – $15.06 |
Stock Statistics
| Market Cap | $3.117B |
|---|
Tokenized Statistics
| Price | - |
|---|---|
| Market Cap | - |
| 24 Hour Trading Vol | - |
| Perps 24h Volume | $668.57 |
| Perps 24h Open Interest | $655,086.87 |
| Perps 8h Funding Rate | 0.0000% |
| Issuers | |
| Contract |
|
| Explorers |
|
| Symbol | ABCL |
Info
| Website |
abcellera.com
|
|---|---|
| Sector |
Health Care
|
| Industry |
Life Sciences Tools & Services
|
| API ID | |
| Asset Type | Stock |
| Country | 🇺🇸 United States |
Recently Happened to Abcellera Biologics
Piper Sandler Raises AbCellera Biologics Price Target to $20
AbCellera Reports Q3 Results and $890 Million in Available Liquidity
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. Its platform integrates technology, data science, infrastructure, and interdisciplinary teams to solve the challenging antibody discovery problems. The company is focused on advancing an internal pipeline of programs and collaborating on drug development programs with partners. Its first two internal programs, ABCL635 and ABCL575, are in late-preclinical studies. ABCL635 is an antibody drug candidate for metabolic and endocrine conditions, and ABCL575 is an antibody drug candidate with broad potential in inflammatory conditions and autoimmune diseases and an initial indication in atopic dermatitis. ABCL575 binds OX40L to disrupt OX40/OX40L signaling, a regulator of inflammatory pathways in AD. In addition to ABCL635 and ABCL575, it is advancing a pipeline of more than 20 internal discovery programs.
How is Abcellera Biologics (ABCL) performing?
Abcellera Biologics (ABCL) is down 6.8% today, trading at $9.62 with a daily range of $9.60 to $10.50. Over the past year, Abcellera Biologics hit a 52-week high of $15.06 and a low of $2.73, and is up 183.0% year-to-date.
What is the market cap of Abcellera Biologics (ABCL)?
Abcellera Biologics (ABCL) has a market cap of $3.12B. To see how ABCL compares to other stocks, check out CoinGecko's list of stocks ranked by market cap.
Who are the different issuers of tokenized Abcellera Biologics (ABCL)?
Robinhood Assets (Jersey) Limited is the only issuer of tokenized Abcellera Biologics on CoinGecko. Their token, ABCL, has a market cap of $4.73K.
Where can I buy tokenized Abcellera Biologics (ABCL)?
Tokenized Abcellera Biologics (ABCL) can be traded on decentralized exchanges. The most popular exchange to buy and trade tokenized ABCL is Uniswap V4 (Robinhood), where the most active trading pair ABCL/ETH has a trading volume of $5.16 in the last 24 hours.
Can I get tokenized Abcellera Biologics data via API?
Yes. Use GET /rwas/abcellera-biologics to get tokenized Abcellera Biologics's latest aggregated market data, including price, market cap and volume, as well as perpetual volume and open interest. For historical data, use GET /rwas/abcellera-biologics/market_chart. Get started with the CoinGecko API, or explore our full range of RWA endpoints.
Abcellera Biologics Markets
| # | Exchange | Pair | Price | Spread | +2% Depth | -2% Depth | 24h Volume | Volume % | Last Updated | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
DEX
|
$10.75 | 0.71% | $45 | $44 | $5.16 | 100.00% |
2 days ago
Inactive - No trades in the last 3 hours
|
||
Abcellera Biologics Derivatives
| # | Exchange | Symbol | Price | 24h | Index Price | Basis | Spread | Funding Rate | Open Interest | 24h Volume | Volume % | Last Updated | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
DEX
|
ABCL/USD
|
$9.78 | 0.3% | $9.76 | -0.045% | 2.64% | 0.0000% | $327,543 | $668.59 | 100.00% |
Recently
|
|
Robinhood Assets (Jersey) Limited
AbCellera Biologics Inc. • Robinhood Token
Robinhood